Nanologica Q2 2024: Improvement in production - Redeye

Redeye maintains a positive outlook on Nanologica following its Q2 report. Production has improved and it seems that the company is poised for growth in the near term. While we mostly maintain our fair value range, we have made some adjustments to our estimates.

Länk till analysen i sin helhet: https://www.redeye.se/research/1018769/nanologica-q2-2024-positive-outlook-in-h2?utm_source=finwire&utm_medium=RSS